Americans’ awareness of the links between body weight and heart health is spotty, a national survey shows. But at least one finding underscores an opportunity for heart-healthy change.
Patients will now have a single point of entry for evidence-based weight management.
Multisite phosphorylation alters adipocyte metabolism via a kinase called S6K1. This pathway could be an attractive target for therapeutic development.
Cleveland Clinic endocrinologists see improved clinical outcomes and patient satisfaction when shared medical appointments are part of the treatment plan for obese patients. An in-depth look at why.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An independent association between obesity and cardiometabolic risk has been tough to prove. Researchers just made the best case yet by using Mendelian randomization to overcome the usual limits of observational studies.
Obesity is like any other chronic disease. Getting the right treatment can make a big difference, says Cleveland Clinic’s W. Scott Butsch, MD.
Bartolome Burguera, MD, PhD, was compelled to become an endocrinologist after seeing the suboptimal care and untoward bias against people suffering from obesity. Today, he serves as Cleveland Clinic’s Director of Obesity Programs in the Endocrinology & Metabolism Institute.
A number of popular diets are reviewed as well as studies evaluating the effect of various diets on weight loss, diabetes and cardiovascular risk factors.
Physicians often ask if they can fit weight counseling into a short office visit. The answer is YES. Information from a pre-visit questionnaire via the electronic medical record can help to facilitate that.
Attend the 12th Annual Cleveland Clinic Obesity Summit, Sept. 28-29, to hear about pharmacologic management, behavioral and lifestyle modification, and surgery.